Weight Loss  +  Wellness
Home > Tirzepatide vs. Semaglutide: Which GLP-1 Is Right for You?

Tirzepatide vs. Semaglutide: Which GLP-1 Is Right for You?

Tirzepatide and semaglutide are two of the most powerful GLP-1 medications available today—but which one is best for your weight loss goals? In this guide, we break down how they compare in effectiveness, side effects, cost, and availability to help you make the right choice.

GLP-1 medications are transforming weight loss and metabolic health. Two names dominate the conversation: semaglutide (sold under Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). Both are powerful—but they’re not identical.

Here’s a head-to-head comparison to help you decide which might be right for your body, goals, and lifestyle.

How They Work

  • Semaglutide is a GLP-1 receptor agonist, mimicking the hormone that helps regulate appetite, insulin, and gastric emptying.
  • Tirzepatide is a dual agonist, acting on both GLP-1 and GIP receptors—giving it a potential edge in weight loss and insulin sensitivity.

Weight Loss Results

Clinical trials have shown that tirzepatide often results in greater weight loss compared to semaglutide, with some participants losing up to 22.5% of their total body weight. In contrast, semaglutide typically yields an average weight loss of 12–15%, depending on the dosage and how long it’s used. However, results can vary significantly between individuals—some patients may respond more effectively to one medication over the other, depending on factors like metabolism, medical history, and lifestyle.

Dosing & Tolerability

Both tirzepatide and semaglutide are administered as once-weekly injections, with doses that are typically titrated up gradually to improve tolerance and reduce side effects.

  • Tirzepatide may cause more gastrointestinal side effects early in treatment, such as nausea or diarrhea. However, these symptoms often lessen as the body adjusts and dosages are modified over time.
  • Semaglutide is generally considered gentler, particularly for first-time users or those who are more sensitive to GI-related issues.

Cost & Availability

When it comes to pricing and access, tirzepatide (sold as Mounjaro or Zepbound) tends to be more expensive, with fewer compounded options compared to semaglutide. However, it is available through trusted telehealth providers, many of which offer direct access to licensed compounding pharmacies. Semaglutide, by contrast, is more widely available and often more affordable, especially when sourced from reputable telehealth platforms that specialize in GLP-1 therapy.

The Verdict

Trying to decide between tirzepatide and semaglutide? The best choice depends on your weight loss goals, sensitivity, and budget. Here’s a quick breakdown:

  • Choose semaglutide if you’re new to GLP-1s, have a more sensitive system, or are looking for the most cost-effective and widely available treatment on the market.
  • Choose tirzepatide if you’re facing stubborn weight plateaus or want a more aggressive fat-loss option. It’s powerful, effective, and now accessible through reliable telehealth providers.

Looking for GLP-1 options that fit your lifestyle and budget? Click here to compare top providers.

Compare dozens of GLP-1 providers

Save time and money finding the best GLP-1 provider for you. Our search tool lets you compare providers using criteria tailored to fit your needs.

Compare dozens of
GLP-1 providers

Save time and money finding the best GLP-1 provider for you. Our search tool lets you compare providers using criteria tailored to fit your needs.

More from the Ultimate Wellness Scroll

Telemeds for me logo white
The Platform is an online aggregator that helps users locate telehealth providers who may prescribe and deliver GLP-1 medications. Telemedsforme.com is not a healthcare provider and does not provide medical services, diagnosis or treatment. We only facilitate the discovery of potential telehealth providers (collectively, the “Third-Party Providers”).

Information on this site is for reference only and doesn't replace professional medical advice. For health-related inquiries, consult your doctor.

*Disclaimer: The FDA-approved brand name drugs, such as Wegovy®, and Ozempic® are exclusively available from the Novo Nordisk® company. Mounjaro® and Zepbound® is exclusively available from Eli Lilly and Company®. TelemedsForMe does not claim any affiliation with, or endorsement from, the above mentioned products or entities.
©2025 TelemedsForMe. All rights reserved.